|
|
 | | | |
- close
- close
- close
- close
Theralase Technologies (TLT) |
QUOTE AND NEWS
Marketwire
Mar 28
Comment
TORONTO, ONTARIO -- (Marketwire) -- 03/28/12 -- Theralase Technologies Inc. (TSX VENTURE:TLT) announced today that its anti-cancer Photo Dynamic Compound (PDC) technology was found to completely destroy subcutaneous (under the skin) colon cancer
Marketwire
Dec 1
Comment
TORONTO, ONTARIO -- (Marketwire) -- 12/01/11 -- (previously released on November 29, 2011), Theralase Technologies Inc. (TSX VENTURE:TLT) announced previously that its patented light activated PDC technology was successful in destroying cancerous
Marketwire
Nov 29
Comment
TORONTO, ONTARIO -- (Marketwire) -- 11/29/11 -- Theralase Technologies Inc. (TSX VENTURE:TLT) announced today it has successfully destroyed cancer cells in an in-vivo subcutaneous malignant tumour model. These results now confirm in a well
Marketwire
Nov 17
Comment
TORONTO, ONTARIO -- (Marketwire) -- 11/17/11 -- Theralase Technologies Inc. (TSX VENTURE:TLT) announced today that it has launched a new version of the high performance Theralase TLC-1000 therapeutic medical laser series, known as the Theralase
Marketwire
Oct 27
Comment
TORONTO, ONTARIO -- (Marketwire) -- 10/27/11 -- Theralase Technologies Inc. (TSX VENTURE:TLT) announced today results of investigational studies demonstrating destruction of specific brain and colon cancer cell lines, when successfully treated with
Theralase Technologies Announces Grant of Stock Options to Board Members and Officers of the Company
Marketwire
Oct 26
Comment
TORONTO, ONTARIO -- (Marketwire) -- 10/26/11 -- Theralase Technologies Inc. (TSX VENTURE:TLT) announced today that stock options totaling 1,200,000 shares, exercisable over a 5 year term at 50 cents per share, and vesting over 3 years, have been
Marketwire
Oct 25
Comment
TORONTO, ONTARIO -- (Marketwire) -- 10/25/11 -- Theralase Technologies Inc. (TSX VENTURE:TLT) is pleased to announce that it has closed a previously announced non-brokered private placement (the "Private Placement") of 1,050,000 units (the "Units")
Marketwire
Sep 14
Comment
TORONTO, ONTARIO -- (Marketwire) -- 09/14/11 -- Theralase Technologies Inc. (TSX VENTURE: TLT) announced today that it has developed a new application for its patented Photo Dynamic Compounds (PDCs); specifically, the destruction of Escherichia coli,
Marketwire
Jul 6
Comment
TORONTO, ONTARIO -- (Marketwire) -- 07/06/11 -- Theralase Technologies Inc. (TSX VENTURE: TLT) is pleased to announce the appointment of Dr. James R. Andrews as Chairman to its Medical and Scientific Advisory Board. Further appointments include
Marketwire
Nov 9
Comment
TORONTO, ONTARIO -- (Marketwire) -- 11/09/10 -- Theralase Technologies Inc. (TSX VENTURE: TLT) has commenced the pre-clinical trial phase of its cancer research project; evaluating its patented Photo Dynamic Compounds (PDCs) in a small animal in-vivo
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
